These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10322910)

  • 1. Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro.
    Wang ZP; Zheng RL; Chen YR; Liu GD
    Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):522-4. PubMed ID: 10322910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
    Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic fibroblast growth factor enhanced LAK cell cytotoxicities against human bladder neoplasm cells.
    Wang ZP; Duan GL; Chen YR; Qin DS; Liu GD; Niu HG
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):276-8. PubMed ID: 10452107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
    Wang ZP; Chen YR; Zheng RL; Lu JZ; Wang JJ
    Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
    Wang Z; Cheng Y; Zheng R; Qin D; Liu G
    Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of prostaglandin E2 or indomethacin on the proliferation of lymphokine-activated killer cells and their cytotoxicity against bladder tumor cells in patients with bladder cancer.
    Wang Z; Chen Y; Zheng R; Qin D; Chen X; Wang Y; Liu G
    Prostaglandins; 1997 Nov; 54(5):769-79. PubMed ID: 9491207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.
    Lin TH; Chu TM
    Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.
    Shemtov MM; Cheng DL; Kong L; Shu WP; Sassaroli M; Droller MJ; Liu BC
    J Urol; 1995 Jul; 154(1):269-74. PubMed ID: 7776443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cell cycle and adoptive immunotherapy using lymphokine-activated killer cells.
    Ejiri Y; Ohara M; Suzuki T; Kasukawa R
    Fukushima J Med Sci; 1997 Dec; 43(2):61-73. PubMed ID: 9640842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines.
    Jackson AM; Hawkyard SJ; Prescott S; Ritchie AW; James K; Chisholm GD
    J Urol; 1992 Jan; 147(1):207-11. PubMed ID: 1729534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of MPS on LAK cell growth and its cytotoxic activity against laryngeal cancer (HEP-2)].
    Wang J; Zhu X; Chen J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):283-6. PubMed ID: 9642362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
    Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
    BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of lymphokine-activated killer cells to lyse mycobacteria-infected cells.
    Chiplunkar SV; Deshmukh MA; Kode JA; Gangal SG; Deo MG
    Acta Leprol; 1997; 10(4):203-8. PubMed ID: 9447253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
    Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle assessment of adoptive transferred lymphokine activated killer cells.
    Watanabe R; Tanaka N; Naomoto Y; Moreira LF; Orita K
    Jpn J Clin Oncol; 1994 Apr; 24(2):59-65. PubMed ID: 8158860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells.
    Yamaue H; Tanimura H; Noguchi K; Iwahashi M; Tsunoda T; Tani M; Tamai M; Hotta T; Mizobata S; Arii K
    J Clin Lab Immunol; 1991 Aug; 35(4):165-70. PubMed ID: 1668852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin coating of bladder tumor cells (T24) is not protective against LAK cell cytotoxicity.
    Carr ME; Sajer SA; Spaulding A
    J Lab Clin Med; 1992 Feb; 119(2):132-8. PubMed ID: 1740625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.